This profile describes access and programme structure. Inclusion is not an endorsement, regulatory finding, or clinical recommendation. Prescription decisions belong to a qualified prescriber.
At a glance
Pricing, medicine, location, care, fulfilment, funding, and policy claims are separated below.
An open check means the public sources were not specific enough—not that the service failed the check.
Resumen en español
Eden para usuarios hispanohablantes
Esta sección ofrece una orientación breve en español sobre el perfil estadounidense. La investigación completa de precios, acceso, farmacia y seguimiento permanece arriba mientras ampliamos la revisión editorial en español.
No encontramos una fuente primaria suficientemente específica para afirmar que una cita clínica esté disponible en español. Confirma el idioma y cualquier servicio de interpretación antes de pagar.
- si la cita concreta será en español;
- el coste mensual ordinario y qué incluye;
- la licencia estatal del profesional;
- el medicamento, la farmacia y el coste por separado.
Esta traducción editorial no demuestra que el proveedor ofrezca atención clínica en español y no sustituye una valoración médica.
Comparar proveedores para hispanohablantes en EE. UU. →How the program is structured
A membership-plus-medication program whose current public pricing clearly separates the $99 recurring membership from medication. Compounded semaglutide and tirzepatide use flat-dose pricing, while FDA-approved brands carry much higher cash prices.
GLP.directory checked the cited public sources on Sep 13, 2026. We reviewed published access, cost, care, fulfilment, funding, cancellation, monitoring, and switching details; we have not audited individual clinical encounters, prescriptions, pharmacy operations, or outcomes.
Availability can change by state, clinician, medical history, product, pharmacy, inventory, and insurance plan. “Not publicly confirmed” means we did not find a sufficiently specific answer in the cited public material. Confirm the current patient-specific answer before paying or changing care.
Service configuration
These structured fields power the directory filters. They describe the reviewed public route and should be reconfirmed for the selected plan.
- Provider type
- Telehealth program
- Medicine context
- Semaglutide (Wegovy; Ozempic/Rybelsus for type 2 diabetes) · Tirzepatide (Zepbound; Mounjaro for type 2 diabetes)
- Formats reviewed
- Injection
- Funding routes
- Private pay
- Service features
- Clinician support · Switching pathway · Home delivery
- Access check
- Confirm current state access
- Evidence status
- Primary sources reviewed
- Research depth
- 2 cited sources · 4 medicine rows · 4 open checks
Recurring cost breakdown
- $39 first membership month; $99/month recurring membership.
- Compounded semaglutide $99/month and compounded tirzepatide $199/month, if prescribed.
- Brand cash prices displayed: Ozempic, Zepbound, and Mounjaro $1,399/month; Wegovy $1,695/month.
- Shipping, clinician review, care-team messaging, and coaching/community access are advertised; confirm plan-specific inclusion.
- Medicine + dose
- Membership or consultation
- Delivery + supplies
- Labs + follow-up
- Renewal after offers
Medication and formulation matrix
| Medication | Form | Regulatory / program path | Published price view |
|---|---|---|---|
| Compounded semaglutide | Injection or other personalized form as offered | Not FDA-approved | $99/month + membership |
| Compounded tirzepatide | Weekly injection | Not FDA-approved | $199/month + membership |
| Ozempic / Zepbound / Mounjaro | Weekly injection | FDA-approved brands; indications differ | $1,399/month + membership |
| Wegovy | Brand treatment | FDA-approved brand | $1,695/month + membership |
Important: “Compounded” means the product is not FDA approved. A brand approved for one condition is not automatically approved for another. The treating clinician determines whether any prescription is appropriate.
State-by-state availability
- Eden says its own pharmacy operates in 30 states and partner pharmacies cover additional locations.
- Medication and pharmacy availability remain state-specific even when the telehealth service accepts the patient.
Clinician access and follow-up cadence
- A licensed provider reviews the health profile and creates a dosing plan.
- Unlimited 24/7 care-team messaging, regular check-ins, and dose adjustment are advertised.
- A guaranteed live-visit cadence is not published.
Pharmacy and fulfillment
- Free expedited home shipping through a certified state-licensed pharmacy is advertised.
- Eden operates a pharmacy in 30 states and uses partners elsewhere; the specific dispenser should be confirmed on the prescription label.
Insurance and prior authorization
- The displayed prices are cash pay and do not require insurance.
- The membership does not include or guarantee a prescription.
Cancellation, refund, and commitment
- No long-term contract or cancellation fee is advertised; cancellation is available in the patient portal.
- Canceling does not stop an order already sent to the pharmacy; a pending order requires contacting support.
Labs, monitoring, and dose management
- A universal included lab panel was not disclosed.
- Ongoing clinical adjustments are advertised, but the precise testing schedule is patient-specific.
Maintenance and switching
- Flat pricing is advertised across dose changes except specified promotions/plans.
- A transfer still requires a new clinical review; confirm current formulation, dose, and pharmacy timing before cancellation elsewhere.
Program snapshot
Treatment-specific cash program
Profiled support: Ongoing clinician access, Simplified intake and fulfillment.
Cash pay
The advertised route is direct cash pay.
Verify before purchase
Ask which licensed pharmacy compounds and dispenses the selected prescription.
What the advertised program may include
- Online intake
- Clinician evaluation
- Treatment when prescribed
- Home delivery on eligible plans
Useful comparison signals
Based on the provider’s published program structure, this profile is tagged for the following searches. These are filters, not endorsements or clinical recommendations.
- Starting care and comparing first-provider requirements
- Switching providers or continuing an established treatment
- Comparing lower-cost access routes and recurring totals
- Ongoing clinician access
- Simplified intake and fulfillment
Open evidence gaps
These are material details we could not confirm precisely enough from the cited public pages. They are the highest-priority questions to resolve directly.
- Public 50-state pharmacy assignment table
- Fixed live-visit cadence
- Universal lab schedule
- Refund handling after dispensing beyond cancellation cutoff
Questions to ask before paying
- What is the ordinary recurring total after any introductory period?
- Does that total include clinician care, medication, supplies, labs, and shipping?
- Which clinician group and dispensing pharmacy will be responsible for my care?
- What happens to billing if I am not prescribed the advertised treatment?
- What records and timing do you require if I am switching from another provider?
Source ledger
Every entry below is a provider-controlled or official public source. A source link documents what was published; it does not independently validate performance, regulatory compliance, safety, or outcomes.
Current membership and medication prices, inclusions, cancellation and support
Owned and partner pharmacy coverage model